Literature DB >> 7537669

MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation.

M Alvarado1, C Klassen, J Cerny, V Horejsí, R E Schmidt.   

Abstract

Previous studies on T cell activation via CD43 antigen stimulation were limited to the use of L10, a monoclonal antibody (mAb) recognizing a sialic acid-independent epitope on the CD43 molecule. Here we study the CD43 mAb MEM-59, which recognizes a neuraminidase-sensitive epitope on the CD43 molecule, for its ability to activate T lymphocytes. The antibody by itself is able to stimulate proliferation of peripheral blood mononuclear cells (PBMC) in a monocyte-dependent fashion, and to act synergistically with the mitogen phorbol 12-myristate 13-acetate. It is demonstrated that the monocyte dependence of MEM-59-induced proliferation of peripheral blood lymphocytes (PBL) cannot be attributed to cross-linking via Fc receptors on monocytes alone: F(ab')2 fragments of MEM-59 are at least as effective as intact IgG in the induction of PBMC proliferation. The effects of MEM-59 reported here are distinct in important ways from those reported for L10. Our proliferation data are extended by the observation that MEM-59 mAb induces mobilization of intracellular Ca2+ in PBMC and in the T cell line Jurkat, while the CD3/TcR-negative Jurkat derived-mutant J.TR3-T3.5 exhibits defective signaling compared to the parent cell line. Moreover, CD3 and CD43 are shown to be present jointly in a large complex in a mild detergent lysate of the T cell line HPB-ALL. These data indicate a physical and functional association between CD3/TcR and CD43 pathways, suggesting a role for CD43 as a co-stimulatory molecule in CD3/TcR signaling, especially in T cell-antigen-presenting cell interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537669     DOI: 10.1002/eji.1830250429

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  CD43, a molecule with multiple functions.

Authors:  Y Rosenstein; A Santana; G Pedraza-Alva
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice.

Authors:  Marijn A Gillissen; Greta de Jong; Martijn Kedde; Etsuko Yasuda; Sophie E Levie; Gemma Moiset; Paul J Hensbergen; Arjen Q Bakker; Koen Wagner; Jullien Villaudy; Pauline M van Helden; Hergen Spits; Mette D Hazenberg
Journal:  Blood Adv       Date:  2017-08-18

3.  Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.

Authors:  Simon Wisnovsky; Leonhard Möckl; Stacy A Malaker; Kayvon Pedram; Gaelen T Hess; Nicholas M Riley; Melissa A Gray; Benjamin A H Smith; Michael C Bassik; W E Moerner; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

4.  CD43 is a ligand for E-selectin on CLA+ human T cells.

Authors:  Robert C Fuhlbrigge; Sandra L King; Robert Sackstein; Thomas S Kupper
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

5.  An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.

Authors:  Maria Elena Bravo-Adame; Rosario Vera-Estrella; Bronwyn J Barkla; Cecilia Martínez-Campos; Angel Flores-Alcantar; Jose Pablo Ocelotl-Oviedo; Gustavo Pedraza-Alva; Yvonne Rosenstein
Journal:  Immunology       Date:  2016-10-12       Impact factor: 7.397

6.  Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling.

Authors:  Jennifer A Fulcher; Margaret H Chang; Shuo Wang; Tim Almazan; Sara T Hashimi; Anna U Eriksson; Xiangshu Wen; Mabel Pang; Linda G Baum; Ram Raj Singh; Benhur Lee
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

7.  High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis.

Authors:  Y W He; M J Bevan
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

8.  Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation.

Authors:  J Stöckl; O Majdic; P Kohl; W F Pickl; J E Menzel; W Knapp
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

9.  Engagement of distinct epitopes on CD43 induces different co-stimulatory pathways in human T cells.

Authors:  Madhura Modak; Otto Majdic; Petra Cejka; Sabrina Jutz; Alexander Puck; Jens G Gerwien; Peter Steinberger; Gerhard J Zlabinger; Herbert Strobl; Johannes Stöckl
Journal:  Immunology       Date:  2016-08-16       Impact factor: 7.397

10.  Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.

Authors:  Daniele Caracciolo; Caterina Riillo; Andrea Ballerini; Giuseppe Gaipa; Ludovic Lhermitte; Marco Rossi; Cirino Botta; Eugénie Duroyon; Katia Grillone; Maria Eugenia Gallo Cantafio; Chiara Buracchi; Greta Alampi; Alessandro Gulino; Beatrice Belmonte; Francesco Conforti; Gaetanina Golino; Giada Juli; Emanuela Altomare; Nicoletta Polerà; Francesca Scionti; Mariamena Arbitrio; Michelangelo Iannone; Massimo Martino; Pierpaolo Correale; Gabriella Talarico; Andrea Ghelli Luserna di Rorà; Anna Ferrari; Daniela Concolino; Simona Sestito; Licia Pensabene; Antonio Giordano; Markus Hildinger; Maria Teresa Di Martino; Giovanni Martinelli; Claudio Tripodo; Vahid Asnafi; Andrea Biondi; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.